Key result
Perioperative beta-blockade may provide cardioprotection in high-risk patients undergoing noncardiac surgery, but routine prophylactic use in low- to intermediate-risk patients is not recommended due to increased risks of stroke and mortality.
Why the study?
Does perioperative beta-blockade reduce cardiac complications in patients undergoing noncardiac surgery?
Does perioperative beta-blockade reduce cardiac complications in patients undergoing noncardiac surgery?
Answers are grounded in this paper and cite their sources.
Routine prophylactic perioperative beta-blockade is not recommended for low- to intermediate-risk patients due to increased risks of stroke and mortality, though carefully titrated therapy may still benefit high-risk patients.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Low et al. (2009) conducted a review in Patients undergoing noncardiac surgery. Perioperative beta-blockers vs. Placebo or standard care was evaluated. Perioperative beta-blockade may provide cardioprotection in high-risk patients undergoing noncardiac surgery, but routine prophylactic use in low- to intermediate-risk patients is not recommended due to increased risks of stroke and mortality.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: